Navigate this market better. Subscribe for FREE stock alerts and information.

Tuesday, December 2, 2014

REFILE-Avanir to be bought by Japan's Otsuka Pharmaceutical for $3.5 bln, (NASDAQ: AVNR)

Avanir Pharmaceuticals Inc said it agreed to be acquired by a unit of Japan's Otsuka Holdings Co Ltd for about $3.5 billion.

AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. Shares of AVNR traded higher by 0.54% or $0.08/share to $15.00. In the past year, the shares have traded as low as $2.62 and as high as $15.34. On average, 6152350 shares of AVNR exchange hands on a given day and today's volume is recorded at 3097228.